Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Steven Rosenberg

Concepts (590)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antigens, Neoplasm
56
2025
310
13.720
 Why?
Lymphocytes, Tumor-Infiltrating
61
2025
209
13.520
 Why?
Receptors, Antigen, T-Cell
55
2024
703
11.340
 Why?
Immunotherapy, Adoptive
53
2024
297
11.110
 Why?
T-Lymphocytes
47
2024
1924
7.670
 Why?
Melanoma
49
2024
752
7.310
 Why?
Neoplasms
35
2025
2475
5.750
 Why?
CD8-Positive T-Lymphocytes
26
2023
847
4.080
 Why?
Gastrointestinal Neoplasms
7
2020
72
3.750
 Why?
Autism Spectrum Disorder
22
2024
385
3.670
 Why?
Immunotherapy
16
2025
588
3.350
 Why?
Adoptive Transfer
18
2024
217
2.840
 Why?
Proto-Oncogene Proteins p21(ras)
8
2022
259
2.760
 Why?
Developmental Disabilities
13
2023
257
2.520
 Why?
Mutation
32
2025
3700
2.520
 Why?
Cancer Vaccines
8
2021
165
2.190
 Why?
Antigens, CD19
9
2022
115
2.130
 Why?
CD4-Positive T-Lymphocytes
12
2022
1048
1.990
 Why?
Skin Neoplasms
13
2020
833
1.880
 Why?
Neoplasm Metastasis
18
2024
616
1.870
 Why?
Autistic Disorder
8
2024
186
1.820
 Why?
Programmed Cell Death 1 Receptor
8
2019
227
1.800
 Why?
Interleukin-2
6
2020
431
1.680
 Why?
Humans
191
2025
129128
1.580
 Why?
ras Proteins
4
2021
145
1.490
 Why?
Colorectal Neoplasms
5
2025
753
1.450
 Why?
Neoplasm Proteins
7
2019
421
1.370
 Why?
Tumor Suppressor Protein p53
6
2022
508
1.330
 Why?
High-Throughput Nucleotide Sequencing
6
2025
485
1.300
 Why?
Epitopes, T-Lymphocyte
9
2021
185
1.240
 Why?
Eligibility Determination
3
2014
63
1.240
 Why?
Genetic Therapy
8
2022
293
1.200
 Why?
Lymphoma, B-Cell
4
2020
104
1.130
 Why?
Membrane Proteins
9
2019
1109
1.130
 Why?
Female
99
2025
68518
1.090
 Why?
Glioblastoma
2
2021
322
1.080
 Why?
Proto-Oncogene Proteins B-raf
4
2019
215
1.060
 Why?
Motor Skills Disorders
4
2016
26
1.030
 Why?
Child Development
7
2024
453
0.990
 Why?
Transcriptome
4
2022
883
0.940
 Why?
Male
83
2025
63202
0.930
 Why?
Genetic Engineering
6
2016
88
0.920
 Why?
Lymphoma, Large B-Cell, Diffuse
2
2017
113
0.910
 Why?
HLA-A2 Antigen
11
2020
47
0.900
 Why?
Middle Aged
53
2025
31080
0.890
 Why?
Cell Line, Tumor
26
2021
3184
0.890
 Why?
Gene Expression Regulation, Neoplastic
7
2019
1353
0.880
 Why?
Flow Cytometry
9
2018
1142
0.840
 Why?
Precision Medicine
3
2015
384
0.840
 Why?
Ovarian Neoplasms
2
2019
490
0.820
 Why?
Tumor Microenvironment
2
2019
622
0.800
 Why?
T-Lymphocyte Subsets
5
2019
410
0.800
 Why?
Medicare Part C
2
2013
30
0.780
 Why?
Single-Cell Analysis
3
2022
274
0.770
 Why?
Coronary Artery Disease
5
2017
678
0.770
 Why?
Cell Separation
4
2019
313
0.760
 Why?
HLA-DP beta-Chains
3
2019
84
0.730
 Why?
Adult
45
2024
35513
0.720
 Why?
Interleukin-12
3
2020
120
0.720
 Why?
Receptors, Antigen
3
2015
15
0.700
 Why?
Hematopoietic Stem Cell Transplantation
3
2022
574
0.690
 Why?
Cognition Disorders
2
2016
497
0.680
 Why?
HLA-A Antigens
2
2021
53
0.670
 Why?
Receptors, Antigen, T-Cell, alpha-beta
4
2020
334
0.670
 Why?
Antigen Presentation
8
2020
205
0.660
 Why?
Retroviridae
2
2022
97
0.650
 Why?
Mutation, Missense
2
2020
318
0.650
 Why?
Interleukin-15
2
2017
82
0.650
 Why?
Colonic Neoplasms
2
2019
242
0.640
 Why?
Mucin-4
1
2019
4
0.640
 Why?
Smad5 Protein
1
2019
8
0.630
 Why?
Child, Preschool
29
2024
10451
0.630
 Why?
Exome
7
2016
220
0.630
 Why?
Aged
32
2025
22090
0.630
 Why?
Temperament
1
2019
47
0.620
 Why?
Cholangiocarcinoma
2
2023
77
0.620
 Why?
Lymphocyte Depletion
2
2016
129
0.620
 Why?
Immunity, Cellular
1
2020
267
0.610
 Why?
Bile Duct Neoplasms
2
2023
99
0.610
 Why?
T-Lymphocytes, Regulatory
2
2019
376
0.610
 Why?
Sequence Analysis, DNA
2
2021
773
0.600
 Why?
ErbB Receptors
2
2019
603
0.580
 Why?
RNA, Messenger
3
2020
2676
0.560
 Why?
Disease Susceptibility
1
2019
335
0.550
 Why?
Genetic Vectors
5
2022
311
0.550
 Why?
Family Characteristics
2
2018
179
0.550
 Why?
Antigens
1
2019
353
0.540
 Why?
History, 20th Century
4
2025
292
0.540
 Why?
Child Behavior
1
2019
236
0.540
 Why?
History, 21st Century
3
2025
180
0.530
 Why?
Social Behavior
2
2023
290
0.530
 Why?
Disabled Children
2
2014
68
0.520
 Why?
Myocardial Perfusion Imaging
2
2013
36
0.520
 Why?
Awards and Prizes
1
2017
62
0.520
 Why?
Communication
2
2023
840
0.520
 Why?
Transposases
1
2016
16
0.520
 Why?
Cell Engineering
1
2016
9
0.510
 Why?
Gene Expression Profiling
8
2019
1689
0.500
 Why?
Lymphoma
1
2017
194
0.500
 Why?
Self-Injurious Behavior
4
2018
120
0.500
 Why?
Psychotherapy
1
2017
159
0.490
 Why?
Bile Ducts, Intrahepatic
2
2023
65
0.490
 Why?
Cell Cycle Checkpoints
1
2016
95
0.490
 Why?
Immunologic Memory
5
2024
341
0.480
 Why?
Surveys and Questionnaires
9
2024
5377
0.470
 Why?
Breast Neoplasms
3
2022
2150
0.450
 Why?
Lymphocytes
1
2016
369
0.440
 Why?
T-Cell Antigen Receptor Specificity
7
2020
51
0.440
 Why?
Lymphocyte Transfusion
1
2013
20
0.430
 Why?
Lymphocyte Activation
10
2020
1098
0.430
 Why?
Sentinel Lymph Node Biopsy
1
2014
108
0.430
 Why?
Indoles
1
2016
372
0.430
 Why?
Th1 Cells
1
2014
136
0.430
 Why?
Vidarabine
4
2017
30
0.430
 Why?
Animals
29
2024
34600
0.420
 Why?
Plaque, Atherosclerotic
1
2014
55
0.420
 Why?
Leukemia
2
2016
229
0.420
 Why?
Histocompatibility Antigens Class I
5
2021
195
0.410
 Why?
Lymph Node Excision
1
2014
165
0.410
 Why?
Child
22
2024
20806
0.410
 Why?
Transplantation Conditioning
4
2019
164
0.410
 Why?
Sulfonamides
1
2016
500
0.400
 Why?
Cyclophosphamide
4
2017
232
0.400
 Why?
Melanoma, Experimental
4
2020
110
0.400
 Why?
Stem Cell Transplantation
1
2013
165
0.400
 Why?
Mice
21
2024
16644
0.390
 Why?
Cell- and Tissue-Based Therapy
3
2019
74
0.390
 Why?
Transfection
1
2014
896
0.390
 Why?
Genes, T-Cell Receptor
3
2022
9
0.380
 Why?
Antibodies, Monoclonal
3
2017
1359
0.370
 Why?
Adaptor Proteins, Signal Transducing
1
2014
391
0.370
 Why?
Melanoma-Specific Antigens
3
2016
5
0.360
 Why?
Biomarkers, Tumor
6
2019
1185
0.360
 Why?
Treatment Outcome
15
2021
10227
0.360
 Why?
Case-Control Studies
13
2024
3342
0.350
 Why?
Lung Neoplasms
3
2022
2329
0.350
 Why?
Neoplasms, Second Primary
2
2022
108
0.350
 Why?
United States
16
2025
13940
0.350
 Why?
Transplantation, Autologous
3
2022
215
0.340
 Why?
Coculture Techniques
3
2021
225
0.340
 Why?
Papillomavirus Infections
3
2018
291
0.340
 Why?
Receptor, ErbB-2
4
2016
336
0.340
 Why?
Papillomaviridae
3
2019
113
0.340
 Why?
Kidney Neoplasms
1
2014
350
0.340
 Why?
gp100 Melanoma Antigen
5
2016
8
0.330
 Why?
Medicaid
1
2014
437
0.330
 Why?
Child Development Disorders, Pervasive
2
2024
61
0.330
 Why?
Infant
11
2017
8993
0.330
 Why?
Coronary Angiography
4
2017
306
0.330
 Why?
Transduction, Genetic
4
2019
128
0.320
 Why?
Peptides
4
2020
911
0.310
 Why?
Combined Modality Therapy
5
2021
1209
0.310
 Why?
Human papillomavirus 16
3
2018
33
0.300
 Why?
Phenotype
6
2024
3058
0.300
 Why?
Gene Expression
6
2016
1462
0.300
 Why?
Repressor Proteins
3
2017
400
0.290
 Why?
Antigens, Differentiation, T-Lymphocyte
2
2020
87
0.290
 Why?
Intellectual Disability
3
2024
152
0.290
 Why?
Tumor Necrosis Factor Receptor Superfamily, Member 9
3
2017
25
0.280
 Why?
Cells, Cultured
8
2021
4010
0.280
 Why?
Prevalence
8
2018
2565
0.280
 Why?
Algorithms
3
2015
1621
0.280
 Why?
Prospective Studies
6
2023
7079
0.270
 Why?
Carcinoma, Squamous Cell
3
2017
621
0.270
 Why?
Neoplasm Staging
5
2018
1293
0.270
 Why?
Dendritic Cells
4
2019
479
0.270
 Why?
Tomography, X-Ray Computed
6
2018
2541
0.270
 Why?
Uterine Cervical Neoplasms
4
2018
235
0.260
 Why?
Oncogene Proteins, Viral
2
2017
22
0.260
 Why?
Young Adult
13
2020
12389
0.260
 Why?
Antineoplastic Combined Chemotherapy Protocols
2
2014
1573
0.260
 Why?
Lymphocyte Count
2
2016
151
0.260
 Why?
Antigens, CD
3
2020
483
0.260
 Why?
Cell Proliferation
8
2019
2347
0.260
 Why?
CD8 Antigens
2
2018
76
0.260
 Why?
Carcinoma
2
2018
214
0.240
 Why?
National Cancer Institute (U.S.)
1
2025
43
0.240
 Why?
Brain Neoplasms
4
2018
1164
0.240
 Why?
Tumor Cells, Cultured
5
2018
930
0.240
 Why?
Whole-Body Irradiation
2
2016
75
0.240
 Why?
Socioeconomic Factors
3
2018
1210
0.230
 Why?
Longitudinal Studies
5
2016
2716
0.230
 Why?
DNA Transposable Elements
2
2016
119
0.230
 Why?
Adolescent
13
2023
20302
0.230
 Why?
T-Lymphocytes, Cytotoxic
2
2015
168
0.230
 Why?
Sensitivity and Specificity
3
2018
1825
0.220
 Why?
Pilot Projects
4
2019
1567
0.220
 Why?
Jaundice, Neonatal
1
2023
9
0.220
 Why?
Immunohistochemistry
4
2016
1671
0.220
 Why?
Disability Evaluation
3
2014
291
0.210
 Why?
Leukocytes, Mononuclear
3
2015
538
0.210
 Why?
Infant, Very Low Birth Weight
2
2014
67
0.210
 Why?
Protein Engineering
2
2014
105
0.210
 Why?
Problem Behavior
2
2022
93
0.210
 Why?
Parks, Recreational
1
2022
10
0.200
 Why?
Proto-Oncogene Proteins
2
2017
634
0.200
 Why?
Constriction, Pathologic
2
2014
229
0.200
 Why?
Time-to-Treatment
1
2024
180
0.200
 Why?
Occupational Therapy
2
2014
85
0.200
 Why?
DNA-Binding Proteins
3
2019
1423
0.200
 Why?
Multiple Myeloma
1
2023
126
0.190
 Why?
Proteasome Endopeptidase Complex
2
2020
145
0.190
 Why?
HEK293 Cells
5
2017
687
0.190
 Why?
Adaptation, Psychological
2
2024
616
0.190
 Why?
Burkitt Lymphoma
1
2022
56
0.190
 Why?
Amino Acid Sequence
4
2020
2041
0.190
 Why?
Clone Cells
2
2019
255
0.190
 Why?
Sex Factors
4
2017
1953
0.190
 Why?
Oncogenes
2
2020
109
0.190
 Why?
Genes, Tumor Suppressor
2
2019
86
0.180
 Why?
Genes, T-Cell Receptor alpha
1
2021
12
0.180
 Why?
Pancreatic Neoplasms
2
2022
878
0.180
 Why?
Apyrase
1
2020
17
0.180
 Why?
Demography
3
2018
277
0.180
 Why?
Gene Expression Regulation
3
2019
2508
0.180
 Why?
Cytokines
6
2022
1987
0.180
 Why?
Lectins, C-Type
1
2020
64
0.180
 Why?
Epitope Mapping
2
2018
57
0.180
 Why?
Oncolytic Virotherapy
1
2020
13
0.180
 Why?
HLA Antigens
2
2021
235
0.170
 Why?
MART-1 Antigen
3
2014
13
0.170
 Why?
Physical Therapy Modalities
2
2014
294
0.170
 Why?
Psychotropic Drugs
1
2021
67
0.170
 Why?
Lymphatic Metastasis
2
2019
318
0.170
 Why?
Mice, Mutant Strains
1
2020
292
0.170
 Why?
Models, Immunological
1
2020
94
0.170
 Why?
Drug Utilization
1
2021
167
0.170
 Why?
Premature Birth
1
2023
312
0.170
 Why?
Virus Replication
1
2022
444
0.170
 Why?
HLA-C Antigens
2
2020
35
0.170
 Why?
Protein Binding
8
2020
2106
0.170
 Why?
Metastasectomy
2
2017
21
0.170
 Why?
Remission Induction
5
2020
271
0.160
 Why?
Neoplasm Recurrence, Local
2
2017
963
0.160
 Why?
Amino Acid Substitution
1
2020
281
0.160
 Why?
Gene Regulatory Networks
1
2022
281
0.160
 Why?
Age Factors
3
2024
3120
0.160
 Why?
Alcohol Oxidoreductases
1
2019
49
0.160
 Why?
Cysteine
1
2020
188
0.160
 Why?
Practice Patterns, Physicians'
2
2021
1270
0.160
 Why?
Gestational Age
2
2024
868
0.160
 Why?
Neoplasms, Glandular and Epithelial
1
2019
35
0.160
 Why?
Area Under Curve
3
2014
282
0.150
 Why?
Referral and Consultation
4
2023
732
0.150
 Why?
Follow-Up Studies
6
2020
4915
0.150
 Why?
Cell Line
4
2022
2737
0.150
 Why?
Behavior Therapy
1
2021
236
0.150
 Why?
Neoplastic Cells, Circulating
1
2019
70
0.150
 Why?
Cohort Studies
6
2016
5407
0.150
 Why?
Medical Oncology
1
2020
274
0.150
 Why?
B-Lymphocytes
3
2020
823
0.150
 Why?
Smoking
2
2018
1466
0.150
 Why?
RGS Proteins
1
2018
14
0.150
 Why?
Trees
1
2018
68
0.150
 Why?
Ubiquitin Thiolesterase
1
2018
42
0.150
 Why?
Mothers
1
2024
729
0.150
 Why?
Forkhead Transcription Factors
1
2019
182
0.150
 Why?
Education, Special
1
2017
24
0.140
 Why?
Parents
4
2022
1308
0.140
 Why?
Lymphoma, Non-Hodgkin
1
2018
76
0.140
 Why?
Psychometrics
2
2019
685
0.140
 Why?
Hematologic Neoplasms
1
2019
139
0.140
 Why?
Tumor Necrosis Factor Ligand Superfamily Member 14
1
2017
4
0.140
 Why?
Uveal Neoplasms
1
2017
11
0.140
 Why?
Self-Examination
1
2017
2
0.140
 Why?
ROC Curve
3
2013
502
0.140
 Why?
Recombinant Fusion Proteins
3
2015
634
0.140
 Why?
Signal Transduction
5
2019
4838
0.140
 Why?
Interferon-gamma
5
2020
762
0.140
 Why?
Population Surveillance
2
2017
428
0.140
 Why?
Societies, Scientific
1
2017
46
0.140
 Why?
Maternal Age
1
2017
123
0.140
 Why?
Extracellular Signal-Regulated MAP Kinases
1
2017
163
0.140
 Why?
Immunologic Surveillance
1
2017
26
0.140
 Why?
Tissue and Organ Procurement
1
2020
289
0.140
 Why?
Administration, Intravenous
1
2017
137
0.140
 Why?
Carcinogenesis
1
2018
209
0.130
 Why?
Disease Progression
5
2017
2613
0.130
 Why?
Prognosis
5
2020
3788
0.130
 Why?
Biomarkers
2
2019
3896
0.130
 Why?
CTLA-4 Antigen
1
2017
89
0.130
 Why?
fas Receptor
2
2015
95
0.130
 Why?
Sialadenitis
1
2016
2
0.130
 Why?
Antineoplastic Agents
2
2017
2060
0.130
 Why?
Peptidomimetics
1
2016
3
0.130
 Why?
Logistic Models
4
2016
1979
0.130
 Why?
WT1 Proteins
1
2016
14
0.130
 Why?
Circulating Tumor DNA
1
2016
29
0.130
 Why?
Green Fluorescent Proteins
2
2015
382
0.130
 Why?
Urinary Bladder Neoplasms
1
2019
226
0.130
 Why?
Mitogen-Activated Protein Kinases
1
2017
313
0.130
 Why?
Coronary Vessels
2
2017
236
0.130
 Why?
HLA-DQ beta-Chains
1
2016
61
0.130
 Why?
ras GTPase-Activating Proteins
1
2015
15
0.130
 Why?
Proto-Oncogene Proteins c-akt
2
2015
421
0.130
 Why?
Immunoglobulin M
1
2017
272
0.130
 Why?
Peer Group
1
2018
225
0.130
 Why?
Clonal Evolution
1
2016
38
0.130
 Why?
Immunoglobulin A
1
2017
202
0.130
 Why?
Transplantation Chimera
1
2016
54
0.130
 Why?
Immunodominant Epitopes
1
2015
28
0.130
 Why?
Molecular Targeted Therapy
1
2019
387
0.130
 Why?
Psychoanalytic Therapy
1
1995
10
0.120
 Why?
Cesarean Section
1
2017
183
0.120
 Why?
T-Lymphocytes, Helper-Inducer
1
2016
137
0.120
 Why?
RNA, Neoplasm
1
2015
87
0.120
 Why?
Epitopes
2
2015
466
0.120
 Why?
Receptors, HIV
1
2015
26
0.120
 Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2016
64
0.120
 Why?
Zinc Fingers
1
2015
43
0.120
 Why?
Psychotherapy, Brief
1
1995
31
0.120
 Why?
Neoplasms, Germ Cell and Embryonal
1
2016
67
0.120
 Why?
Language
1
2018
284
0.120
 Why?
Sarcoma, Synovial
1
2014
16
0.120
 Why?
Odds Ratio
2
2014
1025
0.120
 Why?
Immunophenotyping
1
2016
312
0.120
 Why?
Immunity, Active
1
2014
10
0.120
 Why?
Alphapapillomavirus
1
2015
40
0.120
 Why?
Receptor-Like Protein Tyrosine Phosphatases, Class 2
1
2014
10
0.120
 Why?
Psychotherapy, Group
1
1995
65
0.120
 Why?
Endoribonucleases
1
2015
70
0.120
 Why?
Clinical Trials as Topic
5
2020
1000
0.120
 Why?
Metalloproteins
1
2014
6
0.120
 Why?
Aspirin
1
2018
378
0.110
 Why?
Managed Care Programs
1
1995
133
0.110
 Why?
Triple Negative Breast Neoplasms
1
2017
191
0.110
 Why?
Clinical Trials, Phase II as Topic
1
2014
71
0.110
 Why?
5' Untranslated Regions
1
2014
55
0.110
 Why?
Hepatitis A Virus Cellular Receptor 2
1
2014
30
0.110
 Why?
Nitric Oxide Synthase Type I
1
2014
29
0.110
 Why?
Thrombotic Microangiopathies
1
2014
15
0.110
 Why?
Echocardiography, Stress
1
2013
20
0.110
 Why?
Ribosomal Proteins
1
2014
77
0.110
 Why?
MAP Kinase Kinase Kinase 5
1
2013
3
0.110
 Why?
Tumor Lysis Syndrome
1
2013
8
0.110
 Why?
Transcription Factors
2
2019
1632
0.110
 Why?
Mice, Transgenic
5
2020
2079
0.110
 Why?
Autografts
1
2013
42
0.110
 Why?
Thioredoxins
1
2013
28
0.110
 Why?
Policy Making
1
2014
88
0.110
 Why?
HLA-DR4 Antigen
1
2013
78
0.110
 Why?
Testis
1
2014
144
0.110
 Why?
Carcinoma, Non-Small-Cell Lung
1
2022
1046
0.110
 Why?
Cross-Sectional Studies
5
2017
5070
0.110
 Why?
Extremities
1
2014
128
0.110
 Why?
Motor Skills
1
2014
91
0.110
 Why?
Cognition
2
2023
1111
0.110
 Why?
Health Care Reform
1
2014
99
0.100
 Why?
Transcriptional Activation
1
2015
356
0.100
 Why?
Immunoglobulin G
1
2017
846
0.100
 Why?
Histones
1
2018
584
0.100
 Why?
Allografts
1
2013
137
0.100
 Why?
Astrocytoma
1
2013
121
0.100
 Why?
Nuclear Proteins
2
2015
660
0.100
 Why?
Psychiatric Status Rating Scales
1
2015
523
0.100
 Why?
Gene Expression Regulation, Enzymologic
1
2014
283
0.100
 Why?
Interferon-alpha
1
2014
192
0.100
 Why?
Radiation Injuries
1
2014
137
0.100
 Why?
Cell Movement
4
2019
939
0.100
 Why?
Likelihood Functions
1
2013
136
0.100
 Why?
Infant, Newborn
4
2023
5739
0.100
 Why?
Nanotechnology
1
2013
119
0.100
 Why?
Esophageal Neoplasms
1
2016
293
0.100
 Why?
Survival Rate
4
2020
1875
0.100
 Why?
Risk Factors
5
2023
9769
0.100
 Why?
Receptors, N-Methyl-D-Aspartate
1
2014
202
0.100
 Why?
Proto-Oncogene Proteins c-bcl-2
1
2013
235
0.100
 Why?
Sarcoma
1
2014
177
0.100
 Why?
Calcinosis
1
2014
232
0.090
 Why?
Propensity Score
1
2013
265
0.090
 Why?
Muscle Proteins
1
2013
229
0.090
 Why?
Cost of Illness
1
2014
289
0.090
 Why?
Killer Cells, Natural
1
2014
426
0.090
 Why?
Anxiety
1
2018
955
0.090
 Why?
Randomized Controlled Trials as Topic
2
2013
1363
0.090
 Why?
Research Design
2
2014
1040
0.090
 Why?
Genome, Human
1
2013
392
0.090
 Why?
Head and Neck Neoplasms
1
2016
534
0.090
 Why?
Health Policy
1
2014
353
0.090
 Why?
Wounds and Injuries
1
2018
719
0.090
 Why?
Xenograft Model Antitumor Assays
3
2020
813
0.090
 Why?
RNA-Binding Proteins
1
2014
388
0.090
 Why?
Exercise Test
1
2013
615
0.090
 Why?
Cytotoxicity, Immunologic
3
2016
218
0.090
 Why?
Genetic Testing
1
2013
427
0.090
 Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2014
940
0.090
 Why?
Decision Support Techniques
1
2013
405
0.080
 Why?
Time Factors
2
2017
6518
0.080
 Why?
Models, Theoretical
1
2013
546
0.080
 Why?
K562 Cells
2
2020
82
0.080
 Why?
Databases, Factual
3
2023
1279
0.080
 Why?
HIV-1
1
2015
842
0.080
 Why?
Adenocarcinoma
1
2016
889
0.080
 Why?
Colorado
2
2017
4396
0.080
 Why?
Protein Kinase Inhibitors
1
2014
872
0.080
 Why?
Coronary Stenosis
1
2008
39
0.080
 Why?
Anti-HIV Agents
1
2015
748
0.080
 Why?
Comorbidity
3
2018
1547
0.070
 Why?
Arthritis, Rheumatoid
1
2017
1109
0.070
 Why?
Double-Blind Method
1
2013
1865
0.070
 Why?
Risk Assessment
2
2014
3260
0.070
 Why?
Apoptosis
2
2013
2438
0.070
 Why?
RNA, Small Interfering
3
2014
571
0.070
 Why?
Neutrophils
1
2013
1195
0.070
 Why?
Neoplasm Transplantation
3
2015
258
0.070
 Why?
Protective Factors
2
2017
92
0.070
 Why?
Mass Screening
2
2020
1159
0.070
 Why?
Faculty
1
2007
137
0.060
 Why?
Cross Reactions
2
2016
128
0.060
 Why?
DNA Mutational Analysis
2
2019
386
0.060
 Why?
Mice, Inbred C57BL
4
2020
5284
0.060
 Why?
Molecular Sequence Data
3
2015
2819
0.060
 Why?
Cardiovascular Diseases
1
2018
2024
0.060
 Why?
CD4 Antigens
2
2016
138
0.060
 Why?
Neutropenia
2
2017
136
0.060
 Why?
Retrospective Studies
5
2024
14571
0.060
 Why?
Mice, Inbred NOD
2
2018
584
0.060
 Why?
Single-Chain Antibodies
2
2015
16
0.060
 Why?
Protein Transport
2
2017
422
0.060
 Why?
Intercellular Junctions
2
2014
39
0.060
 Why?
Physical Examination
2
2017
236
0.060
 Why?
GPI-Linked Proteins
2
2014
67
0.060
 Why?
Lung
1
2016
3752
0.050
 Why?
Parity
1
2024
121
0.050
 Why?
Nerve Tissue Proteins
2
2020
568
0.050
 Why?
Receptor, Fibroblast Growth Factor, Type 2
1
2023
24
0.050
 Why?
Point Mutation
2
2014
224
0.050
 Why?
Health Facilities
1
2023
80
0.050
 Why?
Autoantigens
2
2016
416
0.050
 Why?
Real-Time Polymerase Chain Reaction
2
2013
326
0.050
 Why?
Bone Marrow
1
2023
268
0.050
 Why?
Minority Groups
1
2024
252
0.050
 Why?
Receptors, Cell Surface
1
2004
371
0.050
 Why?
Cluster Analysis
2
2014
478
0.050
 Why?
Linear Models
1
2024
816
0.050
 Why?
Alleles
2
2015
845
0.050
 Why?
Skin
2
2019
719
0.050
 Why?
Severity of Illness Index
2
2023
2739
0.050
 Why?
Oligonucleotide Array Sequence Analysis
2
2014
757
0.050
 Why?
Educational Status
1
2023
473
0.040
 Why?
Recombinant Proteins
2
2014
1284
0.040
 Why?
Proportional Hazards Models
1
2024
1210
0.040
 Why?
Parenting
1
2024
296
0.040
 Why?
Predictive Value of Tests
2
2017
1943
0.040
 Why?
Models, Genetic
2
2013
591
0.040
 Why?
Jurkat Cells
1
2020
131
0.040
 Why?
Glioma
1
2004
354
0.040
 Why?
Immunoglobulins
1
2020
157
0.040
 Why?
Base Sequence
2
2014
2135
0.040
 Why?
Cysteine Endopeptidases
1
2020
67
0.040
 Why?
Caregivers
2
2018
812
0.040
 Why?
Early Diagnosis
1
2020
236
0.040
 Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2019
69
0.040
 Why?
Health Care Surveys
1
2021
558
0.040
 Why?
Hydrolysis
1
2019
185
0.040
 Why?
GTP Phosphohydrolases
1
2019
84
0.040
 Why?
Fusion Regulatory Protein 1, Heavy Chain
1
2018
2
0.040
 Why?
Protein Domains
1
2020
252
0.040
 Why?
Forests
1
2018
57
0.040
 Why?
GTP-Binding Protein alpha Subunits, Gi-Go
1
2018
17
0.040
 Why?
Cervix Uteri
1
2018
51
0.040
 Why?
Nuclear Localization Signals
1
2017
15
0.040
 Why?
Healthcare Disparities
1
2024
581
0.040
 Why?
Uterine Cervical Dysplasia
1
2018
43
0.040
 Why?
Mice, SCID
1
2018
347
0.040
 Why?
Hydrogen Bonding
1
2018
149
0.040
 Why?
Disulfides
1
2018
96
0.040
 Why?
Platelet Aggregation
1
2018
91
0.040
 Why?
Ligands
2
2013
614
0.040
 Why?
Eye Enucleation
1
2017
11
0.030
 Why?
Human papillomavirus 18
1
2017
15
0.030
 Why?
Response Evaluation Criteria in Solid Tumors
1
2017
17
0.030
 Why?
Protein Stability
1
2018
161
0.030
 Why?
GTP-Binding Protein alpha Subunits
1
2017
14
0.030
 Why?
GTP-Binding Protein alpha Subunits, Gq-G11
1
2017
18
0.030
 Why?
Culture Media, Serum-Free
1
2016
49
0.030
 Why?
Lymphopenia
1
2017
59
0.030
 Why?
Binding Sites
1
2020
1241
0.030
 Why?
Peptide Fragments
2
2015
686
0.030
 Why?
Drug Synergism
1
2017
358
0.030
 Why?
Vaccinia virus
1
2016
43
0.030
 Why?
Antigen-Presenting Cells
1
2017
150
0.030
 Why?
HLA-DRB1 Chains
1
2017
108
0.030
 Why?
Adenosine Triphosphate
1
2019
471
0.030
 Why?
Blood Chemical Analysis
1
2017
96
0.030
 Why?
Salivary Glands, Minor
1
2016
9
0.030
 Why?
Asymptomatic Diseases
1
2017
85
0.030
 Why?
Tissue Array Analysis
1
2016
57
0.030
 Why?
Health Surveys
1
2018
492
0.030
 Why?
Radiotherapy
1
2017
185
0.030
 Why?
Neoplasm Invasiveness
1
2018
480
0.030
 Why?
Leukemia, B-Cell
1
2016
13
0.030
 Why?
Machine Learning
1
2021
447
0.030
 Why?
Cell Membrane
1
2020
722
0.030
 Why?
Feasibility Studies
1
2020
862
0.030
 Why?
Palate
1
2016
33
0.030
 Why?
HLA-A1 Antigen
1
2015
4
0.030
 Why?
Fas Ligand Protein
1
2015
59
0.030
 Why?
Antigen-Antibody Reactions
1
2015
51
0.030
 Why?
Genes, erbB-2
1
2015
28
0.030
 Why?
MAP Kinase Signaling System
1
2017
303
0.030
 Why?
Health Promotion
1
2022
718
0.030
 Why?
Salvage Therapy
1
2016
138
0.030
 Why?
Anemia
1
2017
161
0.030
 Why?
Anus Neoplasms
1
2015
30
0.030
 Why?
Interferon-gamma Release Tests
1
2015
32
0.030
 Why?
Compulsive Behavior
1
2015
7
0.030
 Why?
Gastrointestinal Diseases
1
2017
197
0.030
 Why?
Necrosis
1
2016
231
0.030
 Why?
Thrombocytopenia
1
2017
182
0.030
 Why?
DNA, Neoplasm
1
2015
159
0.030
 Why?
HIV Envelope Protein gp120
1
2015
57
0.030
 Why?
Cloning, Molecular
1
2016
522
0.030
 Why?
HIV Antibodies
1
2015
57
0.030
 Why?
Dermatitis
1
2014
20
0.030
 Why?
Protein Conformation
1
2018
853
0.030
 Why?
Income
1
2016
189
0.030
 Why?
Metabolic Clearance Rate
1
2014
103
0.030
 Why?
Desmoplakins
1
2014
19
0.030
 Why?
Regression Analysis
1
2017
984
0.030
 Why?
Transplantation, Homologous
1
2016
396
0.030
 Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2015
147
0.030
 Why?
Monophenol Monooxygenase
1
2014
7
0.030
 Why?
Models, Statistical
1
2018
626
0.030
 Why?
Cell Survival
1
2017
1077
0.030
 Why?
Nausea
1
2014
108
0.030
 Why?
Comparative Genomic Hybridization
1
2014
32
0.030
 Why?
Gene Library
1
2014
116
0.030
 Why?
Mice, Inbred BALB C
1
2017
1230
0.030
 Why?
Sleep Wake Disorders
1
2017
249
0.030
 Why?
Random Allocation
1
2014
346
0.030
 Why?
National Institutes of Health (U.S.)
1
2014
125
0.030
 Why?
MAP Kinase Kinase 4
1
2013
28
0.030
 Why?
Social Class
1
2016
259
0.030
 Why?
Infusions, Intravenous
1
2014
385
0.030
 Why?
Histocompatibility Antigens
1
2014
107
0.030
 Why?
Substrate Specificity
1
2014
367
0.030
 Why?
Graft vs Host Disease
1
2016
237
0.030
 Why?
Tumor Burden
1
2014
283
0.030
 Why?
Health Services Accessibility
1
2021
897
0.030
 Why?
X-Ray Diffraction
1
2013
94
0.030
 Why?
Lentivirus
1
2013
52
0.030
 Why?
Radiotherapy, Adjuvant
1
2014
211
0.030
 Why?
Confidence Intervals
1
2014
319
0.030
 Why?
Structure-Activity Relationship
1
2014
531
0.030
 Why?
Immunoenzyme Techniques
1
2013
206
0.030
 Why?
Immunoprecipitation
1
2013
157
0.030
 Why?
Fever
1
2014
301
0.030
 Why?
Reproducibility of Results
2
2012
3033
0.030
 Why?
Models, Molecular
1
2018
1483
0.030
 Why?
Bias
1
2013
195
0.030
 Why?
Drug Administration Schedule
1
2014
758
0.030
 Why?
Histocompatibility Antigens Class II
1
2014
360
0.020
 Why?
Cost-Benefit Analysis
1
1995
582
0.020
 Why?
DNA Primers
1
2013
510
0.020
 Why?
Cotinine
1
2012
75
0.020
 Why?
Receptors, Immunologic
1
2013
209
0.020
 Why?
Spleen
1
2014
513
0.020
 Why?
Bayes Theorem
1
2013
372
0.020
 Why?
Liver Neoplasms
1
2017
643
0.020
 Why?
Pregnancy
1
2023
6375
0.020
 Why?
Blotting, Western
1
2013
1169
0.020
 Why?
Carrier Proteins
1
2014
732
0.020
 Why?
Multivariate Analysis
1
2014
1496
0.020
 Why?
Dose-Response Relationship, Drug
1
2014
1945
0.020
 Why?
Aged, 80 and over
2
2014
7066
0.020
 Why?
Kinetics
1
2013
1617
0.020
 Why?
Tumor Necrosis Factor-alpha
1
2015
1192
0.020
 Why?
Phosphorylation
1
2014
1687
0.020
 Why?
Infant, Premature
1
2014
539
0.020
 Why?
North Carolina
1
2008
100
0.020
 Why?
Germany
1
2008
99
0.020
 Why?
Self Report
1
2012
806
0.020
 Why?
Cell Differentiation
1
2015
1901
0.020
 Why?
Education of Intellectually Disabled
1
1987
3
0.020
 Why?
Disease Models, Animal
1
2018
3953
0.020
 Why?
Vaccination
1
2016
1349
0.020
 Why?
Models, Biological
1
2014
1695
0.020
 Why?
Intelligence
1
2007
129
0.020
 Why?
MicroRNAs
1
2013
677
0.020
 Why?
Polymorphism, Single Nucleotide
1
2013
2065
0.020
 Why?
Receptors, Urokinase Plasminogen Activator
1
2004
14
0.010
 Why?
Urokinase-Type Plasminogen Activator
1
2004
29
0.010
 Why?
Transplantation, Heterologous
1
2004
187
0.010
 Why?
Species Specificity
1
2004
570
0.010
 Why?
Mice, Nude
1
2004
683
0.010
 Why?
Neovascularization, Pathologic
1
2004
291
0.010
 Why?
Down Syndrome
1
1987
471
0.010
 Why?
Polyethylene Glycols
1
2004
597
0.010
 Why?
Endothelium, Vascular
1
2004
872
0.010
 Why?
Rosenberg's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (590) concept(s)
_
Co-Authors Expand Description
See all (10) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)